Target intelligence / Profile preview

Monocyte-mediated cytokine induction

Molecular classification
Other
01

Overview

"Monocyte-mediated cytokine induction" refers to the process by which **monocytes**, a subset of white blood cells, become activated in response to various stimuli (such as pathogens or inflammatory cytokines) and subsequently produce and secrete **cytokines** and **chemokines**[2][5]. This function is crucial for orchestrating the immune response, recruiting and activating additional immune cells, and both initiating and resolving inflammation[4][5]. Dysregulation of this process can contribute to pathological inflammation observed in infection, autoimmune diseases, and other immune-mediated tissue injuries[6][9]. Because the term does not refer to a discrete molecular entity but a process involving multiple cytokines, cell surface receptors, and signaling pathways, it cannot be classified as a canonical drug target or receptor. This entry is a **biological process**, not a molecular target or receptor, and should not be treated as a canonical target entry. "Monocyte-mediated cytokine induction" describes the induction and release of cytokines by monocytes during immune responses, not a single molecule or protein target. For true targets, one should look for specific cytokines (e.g., "Tumor necrosis factor alpha"), cytokine receptors (e.g., "Interleukin-1 receptor"), or monocyte surface markers (e.g., "CD14").

Other names
Monocyte cytokine secretionMonocyte cytokine inductionMonocyte-derived cytokines
02

Biological functions

Immune responseInflammationSecretation of cytokines and chemokinesRecruitment of immune cellsRegulation of tissue homeostasis and repair
03

Disease associations

InflammationInfectionAutoimmune diseaseCardiovascular diseaseNeuroinflammationCancer (inflammatory tumor microenvironment)
04

Safety considerations

Excessive or prolonged monocyte-mediated cytokine induction is implicated in cytokine storm syndromes, sepsis, autoimmune diseases, and tissue damage
05

Biomarkers

Circulating monocyte countsSerum cytokine levels (e.g., TNF-α, IL-6, IL-1β)Expression of monocyte surface markers (such as CD14, CD16)

Beyond the preview

Go deeper on Monocyte-mediated cytokine induction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monocyte-mediated cytokine induction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call